Cinomac HS Injection 1 ml belongs to the group of medicines called oxytocic agents indicated for the prevention of uterine atony and postpartum haemorrhage following cesarean section under epidural or spinal anaesthesia. Postpartum haemorrhage is a condition in which excessive bleeding occurs following childbirth
Cinomac HS Injection 1 ml contains Carbetocin, which is similar to oxytocin, which is naturally produced by the body and helps the womb contract during childbirth. Cinomac HS Injection 1 ml makes the womb contact and reduces the risk of bleeding.
In some cases, Cinomac HS Injection 1 ml may cause abdominal pain, dizziness, feeling of warmth, headache, nausea, and vomiting. Most of these side effects may not require medical attention and resolve gradually over time. However, if the side effects persist or worsen, consult a doctor.
Do not receive Cinomac HS Injection 1 ml if you are pregnant. Consult the doctor if you are breastfeeding. Cinomac HS Injection 1 ml is not recommended for children as safety and effectiveness have not been established. Keep your doctor informed about your health condition and medications to rule out any interactions/side effects.